These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8059520)

  • 21. Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures.
    Cutts T; Leung A; Banadyga L; Krishnan J
    Viruses; 2024 Aug; 16(9):. PubMed ID: 39339831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK
    Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to treat a patient with indications for an infectious viral hemorrhagic fever].
    Visser LG; Schippers EF; Swaan CM; van den Broek PJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2183-8. PubMed ID: 12467160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with suspected viral hemorrhagic fever.
    Centers for Disease Control (CDC)
    MMWR Suppl; 1988 Feb; 37(3):1-16. PubMed ID: 3126390
    [No Abstract]   [Full Text] [Related]  

  • 25. [Viral hemorrhagic fevers in man].
    Simpson DI
    Bull World Health Organ; 1979; 57(1):19-32. PubMed ID: 34489
    [No Abstract]   [Full Text] [Related]  

  • 26. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.
    Mattiuzzo G; Bentley EM; Page M
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31450611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Marburg, Lassa and Ebola virus as cause of hemorrhagic fever].
    Siegert R
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1176-81. PubMed ID: 352653
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivating Lassa and Marburg/Ebola viruses.
    Pereira MS
    Lancet; 1982 Jul; 2(8290):155. PubMed ID: 6123862
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nasty viruses--Lassa, Marburg, and Ebola.
    Simpson DI
    Br J Hosp Med; 1980 Feb; 23(2):191, 193-4. PubMed ID: 6768412
    [No Abstract]   [Full Text] [Related]  

  • 32. Filoviridae: a taxonomic home for Marburg and Ebola viruses?
    Kiley MP; Bowen ET; Eddy GA; Isaäcson M; Johnson KM; McCormick JB; Murphy FA; Pattyn SR; Peters D; Prozesky OW; Regnery RL; Simpson DI; Slenczka W; Sureau P; van der Groen G; Webb PA; Wulff H
    Intervirology; 1982; 18(1-2):24-32. PubMed ID: 7118520
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of Filoviridae: Marburg and Ebola viruses.
    Beer B; Kurth R; Bukreyev A
    Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hemorrhagic fevers.
    Lacy MD; Smego RA
    Adv Pediatr Infect Dis; 1996; 12():21-53. PubMed ID: 9033974
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
    Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
    Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology. Emerging disease or diagnosis?
    Gire SK; Stremlau M; Andersen KG; Schaffner SF; Bjornson Z; Rubins K; Hensley L; McCormick JB; Lander ES; Garry RF; Happi C; Sabeti PC
    Science; 2012 Nov; 338(6108):750-2. PubMed ID: 23139320
    [No Abstract]   [Full Text] [Related]  

  • 38. [Highly contagious diseases with human-to-human transmission].
    Rybka A; Szanyi J; Kapla J; Plíšek S
    Klin Mikrobiol Infekc Lek; 2012 Dec; 18(6):180-3. PubMed ID: 23386507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: management of patients with suspected viral hemorrhagic fever--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jun; 44(25):475-9. PubMed ID: 7783731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A consideration of the diagnosis of dangerous infectious fevers in South Africa.
    Gear JH; Ryan J; Rossouw E
    S Afr Med J; 1978 Feb; 53(7):235-7. PubMed ID: 565951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.